Coronary Clinical Trials

898 recruitingLast updated: May 13, 2026

There are 898 actively recruiting coronary clinical trials across 75 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include Seoul, South Korea, Beijing, Beijing Municipality, China, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Coronary Trials at a Glance

898 actively recruiting trials for coronary are listed on ClinicalTrialsFinder across 6 cities in 75 countries. The largest study group is Not Applicable with 330 trials, with the heaviest enrollment activity in Seoul, Beijing, and New York. Lead sponsors running coronary studies include China National Center for Cardiovascular Diseases, Fundación EPIC, and Seung-Jung Park.

Treatments under study

About Coronary Clinical Trials

Looking for clinical trials for Coronary? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 898 trials

Recruiting
Phase 4

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University6,000 enrolled96 locationsNCT06909565
Recruiting
Phase 4

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

Coronary Artery Disease
University of Florida78 enrolled1 locationNCT06821191
Recruiting
Not Applicable

Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions

Coronary Artery Disease
Chonnam National University Hospital256 enrolled8 locationsNCT06954714
Recruiting

Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries

Myocardial InfarctionCoronary Microvascular DysfunctionVasospasm, Coronary
Chonnam National University Hospital150 enrolled1 locationNCT05272618
Recruiting
Not Applicable

Coronary Artery Disease Assessment Strategies in TAVI Patients

Coronary Artery DiseaseTranscatheter Aortic Valve ReplacementHeart Disease Risk Factors
Insel Gruppe AG, University Hospital Bern546 enrolled1 locationNCT06559332
Recruiting
Phase 4

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

Coronary Artery Disease (CAD)
Insel Gruppe AG, University Hospital Bern816 enrolled1 locationNCT07565805
Recruiting
Not Applicable

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Heart FailureCoronary Artery DiseaseCoronary Artery Disease (CAD)+5 more
University Medical Center Groningen358 enrolled1 locationNCT07269366
Recruiting

Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting

Coronary Artery Bypass
Peking University Third Hospital300 enrolled1 locationNCT06961136
Recruiting
Phase 4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Coronary Artery Disease
Massachusetts General Hospital200 enrolled1 locationNCT05850091
Recruiting
Not Applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation1,616 enrolled50 locationsNCT06959524
Recruiting

Florbetaben for Imaging of Vascular Amyloid

StrokeAcute Coronary SyndromeTransient Ischemic Attack+1 more
Ottawa Heart Institute Research Corporation30 enrolled1 locationNCT06091319
Recruiting

AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)

AI (Artificial Intelligence)BiomarkersMyocardial Ischemia+4 more
University of Galway10,000 enrolled1 locationNCT07577609
Recruiting
Not Applicable

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

AnesthesiologyAnalgesiaPercutaneous Coronary Intervention+2 more
Istanbul University - Cerrahpasa100 enrolled1 locationNCT06576128
Recruiting
Not Applicable

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Coronary Artery Disease
Teleflex150 enrolled19 locationsNCT06779630
Recruiting

SSVC-CI During CABG

Coronary Artery Bypass Grafting Surgery (CABG)
Milton S. Hershey Medical Center120 enrolled1 locationNCT06645327
Recruiting

Correlation of FFR CT With Invasive FFR in Multi-ethnic Cohort- a Retrospective Study

Coronary Artery Disease
Sandwell & West Birmingham Hospitals NHS Trust500 enrolled1 locationNCT06790836
Recruiting

Coroflex® ISAR NEO PMCF Study

Coronary Artery Disease (CAD)Ischemic Heart Disease
Fundación EPIC3,000 enrolled22 locationsNCT05698732
Recruiting
Not Applicable

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

ANOCA - Angina With Non-obstructive Coronary ArteriesINOCA (Ischemia With Non Obstructive Coronary Artery Disease)
Baylor Research Institute50 enrolled1 locationNCT06896903
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782